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Abstract
Objective: Erectile dysfunction (ED) is considered as an early sign of vascular disease due to its high prevalence in patients
with cardiovascular risk factors. Endothelial and neural dysfunction involving nitric oxide (NO) are usually implicated in the
pathophysiology of the diabetic ED, but the underlying mechanisms are unclear. The present study assessed the role of
oxidative stress in the dysfunctional neural vasodilator responses of penile arteries in the obese Zucker rat (OZR), an
experimental model of metabolic syndrome/prediabetes.
Methods and Results: Electrical field stimulation (EFS) under non-adrenergic non-cholinergic (NANC) conditions evoked
relaxations that were significantly reduced in penile arteries of OZR compared with those of lean Zucker rats (LZR). Blockade
of NO synthase (NOS) inhibited neural relaxations in both LZR and OZR, while saturating concentrations of the NOS
substrate L-arginine reversed the inhibition and restored relaxations in OZR to levels in arteries from LZR. nNOS expression
was unchanged in arteries from OZR compared to LZR and nNOS selective inhibition decreased the EFS relaxations in LZR
but not in OZR, while endothelium removal did not alter these responses in either strain. Superoxide anion production and
nitro-tyrosine immunostaining were elevated in the erectile tissue from OZR. Treatment with the NADPH oxidase inhibitor
apocynin or acute incubation with the NOS cofactor tetrahydrobiopterin (BH4) restored neural relaxations in OZR to levels in
control arteries, while inhibition of the enzyme of BH4 synthesis GTP-cyclohydrolase (GCH) reduced neural relaxations in
arteries from LZR but not OZR. The NO donor SNAP induced decreases in intracellular calcium that were impaired in arteries
from OZR compared to controls.
Conclusions: The present study demonstrates nitrergic dysfunction and impaired neural NO signalling due to oxidative
stress and nNOS uncoupling in penile arteries under conditions of insulin resistance. This dysfunction likely contributes to
the metabolic syndrome-associated ED, along with the endothelial dysfunction also involving altered NO signalling.
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Introduction
Erectile dysfunction (ED) is currently considered as an early
clinical sign of vascular disease due to its high prevalence in
patients with cardiovascular risk factors including diabetes,
hypertension and hyperlipidemia [1,2]. ED is a common
complication and an important cause of decreased quality of life
in men with diabetes, male impotence being three times more
prevalent in type 1 and type 2 diabetic patients than in the general
population [3,4].
Penile erection is a complex and multifactorial hemodynamic
process involving organic pathways that require hormonal balance
and neuronal and vascular function integrity [5,6]. Erection is
initiated by activation of parasympathetic nerves upon sexual
stimulation, neural signs from the spinal cord stimulating neuronal
nitric oxide synthase (nNOS) activity and NO production from
non-adrenergic non-cholinergic (NANC) nerve terminals thereby
causing an increase in blood flow to the cavernosal tissue [5,6,7].
Endothelial NOS (eNOS) is then activated by the continued shear
stress on the endothelial lining of the sinusoidal spaces and arteries,
which continues to produce endothelial-derived NO thus main-
taining the sustained phase of penile erection [6,7,8].
Diabetic patients have an increased risk of vascular and nerve
dysfunction and both autonomic neuropathy and endothelial
dysfunction are considered the main etiological factors in the
diabetic ED [9,10]. Hyperglycemia, oxidative stress and altered
lipid profiles contribute to vascular complications including
peripheral nerve perfusion deficits which play an important role
in the etiology of diabetic neuropathy [11]. Impairment of the
NO-mediated neural and endothelial relaxations was first
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diabetic patients [12]. Since then, several in vitro and in vivo studies
in animals and humans have demonstrated that a dysfunctional
nitrergic system underlies the pathophysiology of ED in diabetes
thus explaining the origin of diabetic impotence [12,13,14,15].
Thus, neuronal and endothelial NO-dependent cavernosal smooth
muscle relaxations are diminished in animal models of type 1
diabetes-associated ED [13,15,16]. Likewise, decreased erectile
responses to pelvic nerve stimulation and impaired NANC nerve-
mediated relaxations in cavernosal tissue have been found in
prediabetic obese Zucker rats (OZR) [17] and in type 2 diabetic
db/db mice, respectively [18,19]. In contrast, enhanced corporal
NANC-mediated relaxations despite impaired erectile function
have been reported in Goto-Kakizaki non-obese type 2 diabetic
rats and suggested as a compensatory mechanism to overcome
restricted pre-penile arterial blood supply [20].
Although impairment of the NO-mediated vasodilator respons-
es is well established, the mechanisms of the nitrergic defect
underlying the diabetes-associated ED are not well understood and
reduced NOS expression levels and activity [14], selective
degeneration of nitrergic nerves to the penis [15,21] and altered
NO signalling [20,22] have been proposed. We have recently
demonstrated endothelial dysfunction and changes in the NO
signalling in the penile endothelium of the OZR [23,24], an
established model of metabolic syndrome/prediabetes-associated
ED [17].
The aim of the present study was to assess whether impairment
of the neural NANC nitrergic relaxations may also contribute to
the diminished erectile function in this model, and if so, to clarify
the mechanisms involved in the nitrergic dysfunction with special
reference to the role of oxidative stress and changes in the NO
signalling.
Materials and Methods
Ethics Statement
The investigation conformed to the European Union Guidelines
for the Care and the Use of Laboratory Animals (European
Economic Community Directive 86/609/EEC) and all the
experimental protocols were approved by the Institutional Animal
Care and Use Committee of Madrid Complutense University.
Animal model
Male OZR (fa/fa, n=25) and their control counterparts, Lean
Zucker rats (LZR) (fa/2, n=25) were purchased from Charles River
Laboratories (Barcelona, Spain) at 8–10 weeks of age. Animals were
housed at the Pharmacy School animal care facility and
maintained on standard chow and water ad libitum until they
were used for study, at 17–19-weeks age.
Dissection and mounting
Rats were killed by cervical dislocation and exanguination. The
penile arteries, first- or second order branches of the rat dorsal
penile artery from LZR and OZR rats were carefully dissected by
removing the connective and fat tissue, as described previously
[23]. Segments of dorsal penile arteries were cut into ring segments
and mounted in parallel in double microvascular myographs
(Danish Myotechnology, Denmark) by inserting two 40 mm
tungsten wires into the vessel lumen. After mounting the arteries
were equilibrated for 30 min in Krebs solution mantained at 37uC
of the following composition (mM): NaCl 119, NaHCO3 25, KCl
4.7, KH2PO4 1.17, MgSO4 1.18, CaCl2 1.5, ethylenediaminetet-
raacetic acid 0.027 and glucose 11, continuously gassed with a
mixture of 5% CO2/95% O2 to maintain pH at 7.4. The
relationship between passive wall tension and internal circumfer-
ence was determined for each individual artery and from this, the
internal diameter, l1, that yielded a circumference equivalent to
90% of that given by an internal pressure of 100 mmHg was
calculated [23].
Experimental procedure
Electrical field stimulation (EFS) was performed through two
electrodes mounted parallel to the vessel segments using a Cibertec
stimulator (Barcelona, Spain) with constant current output.
Squared pulses of 0.3 ms duration in 20 s trains with varying
frequencies (0.5 to 16 Hz) were applied. Voltage of the stimulator
was adjusted to deliver 35 mA. Changes on isometric force were
recorded. At the beginning of each experiment, arteries were
challenged once with 120 mM K
+ (high K
+-physiological saline
solution, KPSS) in order to verify the contractile ability of the
preparations. To assess the relaxant responses to nerve stimulation
under NANC conditions, penile arteries from LZR and OZR were
incubated with guanethidine (10
25 M) plus atropine (10
26 M), to
inhibit adrenergic and cholinergic responses, respectively, and
these drugs were kept present throughout the experiment to block
NANC-mediated responses. To evaluate a-adrenergic nerve-
mediated responses, EFS curves (0.5 to 32 Hz) were obtained on
resting tension in the presence of the b-adrenergic blocker
propranolol (10
26 M) and in the absence and presence of the
non-selective NOS inhibitor N
G-nitro-L-arginine (L-NOARG,
10
24 M). The role of the vascular endothelium was examined in
arteries where the endothelium was mechanically removed by
inserting a human hair in the vessel lumen and guiding it back and
forwards several times. The absence of functional endothelium was
confirmed by lack of the relaxation to acetylcholine (10
25 M).
A first frequency-response EFS curve (0.5 to 16 Hz) was
obtained in phenylephrine (Phe) (10
26 M) precontracted arteries
to compare LZR and OZR penile arteries relaxations. The effects
of the NOS inhibitor L-NOARG (10
24 M), of the substrate of NO
synthesis, L-arginine (3610
23 M) and of L-arginine plus L-
NOARG were tested before a second and third EFS curves were
performed. The effects of mechanical removal of the endothelium,
the selective inhibition of nNOS with N
W-propyl-L-arginine
hydrochloride (L-NPA, 3610
26 M), scavengers of superoxide
such as the superoxide dismutase (SOD) mimetic tempol
(3610
25 M) and the inhibitor of the nicotinamide adenine
dinucleotide phosphate oxydase (NADPH) apocynin (10
24 M)
were also assessed on the relaxations induced by EFS under
NANC conditions. Treatment of penile arteries with the NOS
cofactor tetrahydrobiopterin (BH4, 10
24 M), with its inactive
stereoisomer (6R,S)-5,6,7,8-tetrahydro-D-neopterin dihydrochlo-
ride (NH4, 10
25 M) as a negative control, and with the inhibitor
of the enzyme for BH4 synthesis GTP-cyclohydrolase, 2,4-
diamino-6-hydroxypirimidine (GCH-I, 3610
24 M) were also
tested on the EFS-induced relaxations. When antagonists or
inhibitors were used, drugs were introduced 30 minutes before a
second concentration- or frequency-response curve was per-
formed, and the Phe concentration was adjusted to match the
contraction during the first control curve.
To assess the endothelium-independent relaxant responses,
cumulative concentration-response curves (CCR) to the NO donor
S-nitroso-N-acetylpenicillamine, SNAP (10
28–10
24 M) were ob-
tained in Phe (10
26 M) pre-contracted penile arteries from LZR
and OZR in the presence or the absence of SOD mimetic tempol
(3610
25 M) or the NADPH oxydase inhibitor, apocynin
(10
24 M).
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Tissue samples from the penis containing the dorsal penile
artery were inmersion-fixed in 4% paraformaldehyde in 0.1 M
sodium phosphate-buffer (PB), cryoprotected in 30% sucrose in PB
and snap frozen in liquid nitrogen and stored at 280uC.
Transversal sections of 10 mm were obtained by means of a
cryostat and processed following the avidin-biotin-peroxidase
complex (ABC) method [25]. Sections were first immersed in a
mixture of 1% H2O2 and 90% methanol in distilled water for
30 min, washed in PB and the pre-incubated in 10% normal goat
serum in PB containing 0.3% Triton-X-100 for 2–3 h. Then,
sections were incubated with a rabbit polyclonal antibody to the
N-terminus of neuronal nitric oxide synthase (nNOS) (AB5380
Chemicon International Inc) diluted 1:500 or with rabbit
polyclonal antibody to Nitro-tyrosine (ab42789 abcam) diluted
1:100 for 48 h at 4uC. Sections were then incubated for 2 h at
room temperature with biotinylated anti-rabbit serum raised in
goat (Chemicon International Inc) diluted 1:400, followed by
incubation with avidin-biotin-complex (ABC, Vector) 1:100
dilution for 90 min at room temperature. The immunocomplex
was visualized with 0.05% 3.3 diaminobenzidine (DAB) and
0.001% in H2O2 in PB. No immunoreactivity could be detected in
sections incubated in the absence of the primary antisera.
Measurement of superoxide production by
chemiluminescence
Changes in the basal levels of superoxide were detected in the
corpus cavernosum by lucigenin-enhanced chemiluminescence, as
previously described in erectile tissue [26]. Corpora cavernosa (4–
5 mm long strips) from LZR and OZR were dissected and
equilibrated in Krebs buffer for 30 minutes at room temperature
and then incubated in the presence or absence of the ROS
scavenger, tempol (3610
25 M) for 30 min at 37uC. The corpus
cavernosum was then transferred to microtiter plate wells
containing 5610
26 M lucigenin (bis-N-methylacridinium nitrate)
in air-equilibrated Krebs solution buffered with 10
22 M HEPES-
NaOH, in the absence (controls) and presence of tempol.
Chemiluminescence was measured in a luminometer (BMG
Fluostar Optima), and for calculation baseline values were
subtracted from the counting values under the different experi-
mental conditions and superoxide production was normalized to
tissue weight.
Measurements of intracellular Ca
2+ ([Ca
2+]i)
Simultaneous measurements of [Ca
2+]i and force were per-
formed in intact penile arteries as previously described [27]. The
myograph was mounted on an inverted microscope (Axiovert
S100 TV) equipped for dual excitation wavelength microfluori-
metry. Penile arteries were incubated in the dark in PSS with
8 mM Fura 2-acetoxymethyl ester for 3 hours at 37uC, changing
the solution after 1.5 h. Then arteries were washed for 45 minutes,
to remove remaining Fura-2 acetoxymethy ester. After loading,
the arteries were illuminated with alternating 340 and 380 nm
light using a monochromator-based system (Deltascan, PTI). The
fluorescence emission was detected at a wavelength of 510 nm. At
the end of each experiment, Ca
2+-insensitive signals were
determined after quenching with 25 mM Mn
2+, and the values
obtained were substracted from those obtained during the
experiment. The Ratio (R) F340/F380 was taken as a measure of
[Ca
2+]i.
Arteries were initially stimulated with KPSS in order to test
vessel viability. Then, cumulative concentration-response curves to
the NO donor SNAP (10
28–10
24 M) were evaluated in arteries
from LZR and OZR pre-contracted with Phe (10
26 M).
Data presentation and statistical analysis
Results are expressed as either Nm
21 of tension or as a percent
of the response to either Phe or KPSS in each artery, as means 6
SEM of 6–10 arteries (1–2 from each animal). Sensitivity of the
arteries to the relaxant agonists or EFS is expressed in terms of
EF50 or EC50 values, where pEF50 is 2logEF50 and pEC50 is
2logEC50,E F 50 or EC50 are the frequency or the concentration of
the agonist, respectively, required to produce 50% of the response
and was calculated by non-linear curve fitting of the frequency-
response curves for the inhibitor to the classical Hill Equation by
using a nonlinear interactive fitting program (Graph Pad Prism
5.0, Graph Pad Software Inc., San Diego, CA, USA). The EF50 or
EC50 value for each individual curve was first obtained and
thereafter the average value for a given set of experiments was
calculated. Statistically significant differences between means were
analysed by one-way ANOVA or using paired or unpaired
Student’s t test when apropiate. Probability levels smaller than 5%
were considered significant.
Results
General Parameters
At the time of the experiment (17–18 weeks of age), OZR were
significantly heavier than LZR (51867 g and 38365 g, respec-
tively, P,0.0001, n=25). We have reported that at this age
animals from the OZR group exhibit mild hyperglycaemia,
hyperinsulinemia and dyslipidemia with elevated total cholesterol
and triglycerides levels [23]. The normalized internal lumen
diameters, l1, were significantly smaller in penile arteries from
OZR compared with LZR (12464 mm, n=49, and 14464 mm,
respectively, n=52, P,0.001). The contractions to KPSS were
reduced in the OZR group (1.260.1 N/m, n=49) compared with
LZR (1.860.13 N/m, P,0.001; n=52), indicating altered
contractility of arterial smooth muscle.
NO-mediated neurogenic relaxations in penile arteries
from LZR and OZR
An impaired neurogenic vasodilator response has been reported
in several models of diabetes-associated ED. Nitrergic inhibitory
neurotransmission was assessed in penile arteries from LZR
compared to OZR. Under NANC conditions, EFS (0.5 to 16 Hz)
induced frequency-dependent relaxations in arteries pre-contract-
ed with Phe which were significantly reduced in OZR compared
with LZR (Figures 1A and B). Thus EF50 were 4.8960.48 (n=8)
and 3.1460.40 (P,0.005, n=7) in LZR and OZR, respectively,
and high frequency stimulation (4 to 16 Hz) produced remarkably
greater relaxant effects in healthy arteries compared with arteries
from OZR (Figure 1B). This suggests an impaired inhibitory
neurotransmission in penile arteries from obese animals.
In order to verify whether the EFS relaxant responses are
specific of nitrergic nerves, the effects of inhibitors and substrates
of NO synthesis were tested. Treatment with L-NOARG (10
24 M)
markedly inhibited the EFS-induced relaxations in penile arteries
from LZR and OZR (Figure 2). Given acutely, the substrate of
NO synthesis L-arginine (3610
23 M) significantly reversed the
inhibition induced by L-NOARG in both groups (Figures 2A and
B), this effect of L-arginine being larger in arteries from obese
animals where NO-dependent relaxations were restored to levels
similar to those in control arteries (Figure 2D). These results
indicate that the vasodilatation induced by EFS in penile arteries
during erection is largely mediated by NO production and
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responses, no significant differences were observed in the
relaxations elicited by the NO donor SNAP between LZR and
OZR (Figure 2E), pEC50 values being 6.3060.21 (n=7) in LZR,
and 6.3960.18 (n=7; P.0.05) in OZR. These results suggest that
the reduced NO neurogenic responses are due to impaired NO
bioavailability in penile arteries from obese rats.
Considering that the penis is kept in the flaccid state mainly by
sympathetic activation and the release of vasoconstrictor nor-
adrenaline, we next assessed the role of NO on the EFS-induced
adrenergic contractions. In the presence of propranolol (10
26 M)
to inhibit b-adrenergic receptors, EFS elicited frequency-depen-
dent contractions that were abolished by the adrenergic toxin
guanethidine (not shown) and significantly enhanced in penile
arteries from OZR (Figure 3A), suggesting an augmented
sensibility to a-adrenergic stimuli. Thus, EF50 values
were18.560.8 (n=7) and 17.561.3 (n=7; P.0.05), and maxi-
mum effect 2963% (n=7) and 4667% (n=7; P,0.05) of the
KPSS induced contraction, in LZR and OZR, respectively. EFS-
induced vasoconstriction was potentiated by treatment with the
NOS blocker L-NOARG (Figures 3B and C), this potentiation
being lesser in penile arteries from OZR (Figure 3C). Thus, the
contractile response induced by EFS at 16 Hz was enhanced after
NOS blockade by 4.5- and 2-fold in LZR and OZR, respectively.
These results indicate that under basal conditions NO modulates
penile adrenergic vasoconstriction and confirm a reduced NO
bioavailability in arteries from obese animals.
nNOS-containing nerves in penile arteries
Reduced NO bioavailability in the diabetic vascular tissue might
be due to reduced NO synthesis due to alterations in either the
content or the activity of the enzyme NOS. Immunostaining of
cross arterial sections with a polyclonal antibody against nNOS
revealed higher nNOS localization not only within the adventitial
perivascular nerves but also in the endothelium lining of penile
arteries (Figure 4A and B). No differences in either the presence or
distribution of this constitutive NOS isoform were observed in
penile arteries from OZR compared to LZR rats (Figure 4A and
B).
Contribution of nNOS to the NO-mediated neurogenic
relaxations in penile arteries
Selective inhibition of nNOS with L-NPA (3610
26 M) resulted
in a significant reduction of the EFS-induced relaxations of penile
arteries from LZR (Figure 4C) indicating that nNOS-derived NO
contributes to the neurogenic relaxations in healthy penile arteries.
In contrast, inhibition of nNOS did not reduce but rather
improved the relaxations at low frequencies of EFS in arteries
from OZR (Figure 4D), which suggests that nNOS activity might
be impaired and the enzyme releases a contractile factor in arteries
from obese animals.
Mechanical endothelium removal did not alter the relaxant
responses to EFS in arteries from either LZR or OZR (Figure 4E
and F), which initially rules out any significant contribution of NO
derived from endothelial NOS to the EFS-induced relaxations of
penile arteries from OZR and LZR.
Role of superoxide production in the impaired
neurogenic NO-mediated responses of penile arteries
from OZR
We next investigated whether reduced NO-mediated responses
could be the result of increased consumption of NO by ROS.
Acute antioxidant treatment by incubating the arteries with the
superoxide dismutase mimetic tempol (3610
25 M) did not affect
the relaxant responses induced by endogenous neural-derived NO
in control arteries (Figure 5A), nor it restored the impaired NO-
mediated responses elicited by EFS in arteries from obese animals
(Figure 5B). However, treatment with the inhibitor of NADPH
oxidase, apocynin (10
24 M) to decrease superoxide production
significantly improved the EFS nitrergic relaxation in OZR
arteries and restored this response to values similar to those in
LZR (Figures 5C and D), indicating that an elevated production of
NADPH oxidase-derived superoxide inhibits neurogenic relaxa-
tions in arteries from obese animals. The relaxations to the NO
donor SNAP were unaltered after tempol treatment in penile
Figure 1. NANC vasorelaxant responses were impaired in
penile arteries from OZR. A. Representative traces showing the
relaxant responses induced by EFS (0.5–16 Hz) in penile arteries
precontracted with Phe (10
26 M) under non-adrenergic non-cholinergic
(NANC) conditions, which were significantly impaired in OZR compared
with LZR. B. Average frequency-response curves for the relaxation to
EFS in penile arteries from LZR and OZR. Data are shown as the means
6 SEM of 7 and 9 arteries (1–2 per animal). * P,0.05, ** P,0.01 vs LZR.
doi:10.1371/journal.pone.0036027.g001
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incubation in OZR (Figures 5E and F).
On the other hand, augmented ROS production in the erectile
tissue of obese rats was evidenced in the immunohistochemical
study by the enhanced 3-nitrotyrosine staining in sections of both
penile arteries and corpus cavernosum. 3-nitrotyrosine immuno-
reactivity was localized primarily in the inner endothelial layer of
penile arteries (Figure 6B) and in the endothelium lining the
cavernous spaces (Figure 6D), and could eventually be found
restricted to small foci in the media layer of the penile arteries from
OZR (Figure 6B). No or slight staining for 3-nitrotyrosine was
observed in erectile tissue from control LZR (Figures 6A and C).
Measurements of basal superoxide generation by lucigenin
chemiluminescence confirmed an enhanced production of super-
oxide in the cavernosum tissue from OZR compared to LZR
(Figure 6E). Preincubation with tempol (3610
25 M) significantly
reduced chemiluminescence in erectile tissue from both LZR and
OZR corpus cavernosum tissue (Figure 6E), confirming specificity
for superoxide (Figure 6E).
Effect of the NOS cofactor BH4 and the inhibitor of GCH-I
on NO-mediated neurogenic relaxations
Reduced NO bioavailability can be the result of NOS
uncoupling to the synthesis of NO due to enhanced oxidative
stress and diminished levels of the NOS cofactor BH4.
Augmenting vascular BH4 levels by pharmacological supplemen-
Figure 2. NO-mediated neural vasorelaxant responses were impaired but the relaxant responses to the NO donor SNAP were
unaltered in penile arteries from OZR. A, B. Representative traces showing the effects of the NOS inhibitor (L-NOARG, 10
24 M) and of L-NOARG
plus the substrate of the NO synthesis L-arginine (L-arginine, 3610
23 M) on the EFS frequency- dependent relaxations (0.5–16 Hz) in penile arteries
from LZR and OZR. Acute treatment with L-arginine restored neural NO-mediated response in OZR to control levels in LZR. C, D. Average frequency-
response curves for the effects of NOS blockade and L-arginine on the relaxations to EFS in penile arteries from LZR and OZR. E. Relaxant responses to
the NO donor SNAP were unaltered in penile arteries from OZR. Concentration-response curves for the relaxant effect of SNAP (10
28–10
24 M) in
penile arteries from LZR and OZR. Results are means 6 SEM of 6–8 arteries.
aP,0.05,
bP,0.01,
cP,0.001 vs control;
dP,0.05,
eP,0.01,
fP,0.001 vs L-
NOARG-treated.
doi:10.1371/journal.pone.0036027.g002
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Preincubation of penile arteries with BH4 (10
24 M) restored
neurogenic NO-mediated vasodilatation in penile arteries from
OZR to levels similar to those in control arteries (Figure 7B), and
had no effect on the LZR EFS-induced relaxations (Figure 7A),
suggesting that reduced BH4 might account for the impaired NO
neurogenic relaxations in OZR. To exclude any antioxidant
effects of BH4, NH4 was used as a negative control, since this
pterin shares with BH4 antioxidant effects but has no influence on
NOS uncoupling. Addition of NH4 (10
25 M) had no effects on
EFS-induced relaxations in either LZR or OZR (Figure 7C and
D). Incubation with the inhibitor of the enzyme of BH4 synthesis
GCH (2,4-diamino-6-hydroxypirimidine, 3610
24 M) significantly
reduced the NO-mediated neurogenic relaxations of penile
arteries from LZR but not from OZR (Figures 7E and F), thus
supporting that impairment of the neurogenic penile relaxations in
obese animals might be due to decreased GCH activity leading to
reduced levels of the cofactor BH4 and to nNOS uncoupling.
Changes in NO calcium signalling
In order to assess whether enhanced oxidative stress could
impair the NO signalling pathways of penile arteries from OZR
despite the preserved NO-induced relaxations, simultaneous
measurements of [Ca
2+]i and tension were performed in arteries
from LZR and OZR. Stimulation of penile arteries from LZR and
OZR with high K
+ solution (KPSS) induced simultaneous
increases in both [Ca
2+]i (D(F340/F380)=0.2360.06, n=5, in
LZR, and 0.3160.05, n=6, in OZR, P.0.05) and tension
(1.8760.50 Nm
21, n=5 in LZR and 1.3760.19 Nm
21,n=6i n
OZR, P.0.05) (Figures 8A and C). The a1-adrenoceptor agonist
Phe (10
26 M) also evoked sustained increases in [Ca
2+]i (D(F340/
F380)=0.1960.04, n=5, in LZR, and 0.2260.03, n=6, in OZR,
P.0.05) and tension (2.0560.47 Nm
21, n=5 in LZR and
1.8460.28 Nm
21, n=6 in OZR, P.0.05) (Figures 8A and C).
The relaxations induced by the NO donor SNAP (10
28–
10
25 M) in arteries pre-contracted with Phe were accompanied by
simultaneous decreases in [Ca
2+]i, especially at the highest
concentrations of SNAP, in penile arteries from LZR (Figures 8A
and B). In contrast, the decreases in [Ca
2+]i induced by SNAP
were impaired in arteries from OZR (Figures 8C and D) while the
relaxant effect was not different from that in control arteries
(Figures 8C and D). Thus, at the highest concentrations applied
(10 mM), SNAP reduced [Ca
2+]i by 7069% in LZR, and by
35612% (P,0.05) of the Phe induced contraction in penile
arteries from OZR (Figures 8B and D).
Discussion
Since NO derived from NANC nerves and endothelium is
essential for penile erection, dysfunction of the nitrergic system
plays a key role in the pathophysiology of vasculogenic ED. The
present study demonstrates altered neural NO-mediated relaxant
responses due to oxidative stress and nNOS uncoupling in penile
arteries from the insulin resistant OZR. This dysfunction likely
contributes, along with the endothelial dysfunction also involving
altered NO signalling [23,24], to the decreased erectile responses
found in this model of metabolic syndrome/prediabetes [17].
The development of a selective nitrergic dysfunction has
consistently been demonstrated in the corpus cavernosum of
diabetic impotent men and in the penis of type 1 diabetic animal
models [12,13,15,21], while nitrergic neural relaxations were
reported to be either deficient [18,19] or augmented to
compensate altered erectile responses [20] in insulin resistance/
type 2 diabetic models. The present study demonstrates that the
NANC inhibitory neurotransmission is markedly impaired in
penile arteries from OZR, which is consistent with the diminished
in vivo erectile responses to stimulation of pelvic nerves reported in
this model of metabolic syndrome [17]. The fact that these neural
relaxant responses were largely inhibited by non-selective NOS
blockade and that this inhibition was reversed by incubation with
the NO synthesis substrate L-arginine, demonstrates that NO is a
main neural mediator involved in these nerve-mediated relaxa-
tions. On the other hand, the lack of effect of endothelial removal,
along with the inhibition elicited by selective nNOS blockade on
the EFS-induced relaxations of healthy penile arteries suggest that
neurogenic relaxations are mediated by NO originating primarily
from neural nNOS. However, selective nNOS inhibition failed to
Figure 3. Neural vasoconstrictor responses were augmented in
penile arteries from OZR in part due to impaired NO release. A.
Average EFS frequency- dependent contractions (1–32 Hz) in penile
arteries from LZR and OZR. B, C. Inhibition of NO synthesis largely
enhanced neural vasoconstrictor responses to EFS agonists in LZR and
to a lesser extent in OZR. Effects of the NOS inhibitor L-NOARG (10
24 M)
on EFS frequency- dependent contractions in penile arteries of LZR and
OZR. Results are mean 6 SEM of 6–8 arteries. *P,0.05, **P,0.01,
***P,0.001 vs control.
doi:10.1371/journal.pone.0036027.g003
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elicited relaxant responses in OZR, thus indicating that the
contribution of nNOS to the neurogenic relaxations is impaired
and the enzyme appears to release a constrictor factor in obese
animals.
Vascular dysfunction in diabetes includes enhanced vasocon-
striction which has been ascribed to either abnormal smooth
muscle reactivity or endothelial dysfunction. Sympathetic nerves
are responsible for penile detumescence through the release of
vasoconstrictor noradrenaline that contracts smooth muscle of
arteries and sinuses [5,6]. The present study shows an enhanced
noradrenergic vasoconstriction elicited by nerve stimulation of
penile arteries from the insulin resistant OZR, in accordance with
the large hypercontractile sensitivity to noradrenergic stimuli
associated to decreased erectile responses reported for animal
models of insulin resistance/type 2 diabetes [17,18]. Interestingly,
this augmented vasoconstriction seems to be due in part to a
dysfunctional nitrergic system, as depicted by the lesser effect of
NOS blockade to augment adrenergic contractions in penile
arteries from OZR. In LZR, inhibition of NO synthesis greatly
enhanced neural noradrenaline-induced contractions thus indi-
cating that NO counteracts noradrenaline responses in healthy
arteries and supporting earlier studies showing that nitrergic
nerves modulate sympathetic vasoconstriction in human penile
erectile tissue [28]. Subsequently, altered NO signalling, as shown
in the present study, likely contributes to the impaired erectile
responses under conditions of insulin resistance not only by
impairing NO-induced vasodilatation but also by augmenting
noradrenaline-mediated antierectile effects.
In the present study, reduced neural NO-mediated vasodilator
responses were not accompanied by diminished relaxations to the
NO donor SNAP in penile arteries from OZR, which initially
suggests an intact NO signalling in smooth muscle but impaired
NO bioavailability. The latter may be a result of reduced NO
Figure 4. NO derived from nNOS contributes to the nerve-mediated relaxations in penile arteries from LZR but not OZR. A, B.
Immunohistochemical demonstration of the presence of nNOS in perivascular nerve fibers: in the adventitia (arrows), and in the endothelial cell layer
(arrow head) of the penile arteries from LZR and OZR. Note that localization of nNOS immunoreaction was similar in LZR and OZR. C, D. Selective
inhibition of nNOS with N
W-propyl-L-arginine hydrochloride (L-NPA, 3610
26 M) reduced the EFS frequency- dependent relaxations in penile arteries
from LZR but not OZR.. E, F. EFS frequency- dependent relaxations were unaltered in endothelium-denuded penile arteries from LZR and OZR.
Results are mean 6 SEM of 5–7 arteries. *P,0.05, **P,0.01, ***P,0.001 vs control.
doi:10.1371/journal.pone.0036027.g004
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content or the activity of the enzyme NOS. Decreased nNOS
expression and activity along with reduced erectile function has
been reported in the penis of type 1 diabetic animals
[14,15,21,29], where a selective nitrergic degeneration has been
demonstrated with loss of nNOS in the nerve fibers and nitrergic
dysfunction [15,21]. In the present study, no apparent changes in
the perivascular nNOS containing nerves of penile arteries from
OZR were observed, which is consistent with the lack of changes
in the nNOS protein content reported for the penis in this model
[17] and also in other models of type 2 diabetes [20]. Interestingly,
nNOS was also localized in the penile endothelium of both healthy
and insulin resistant obese animals, which is in agreement with
earlier reports in the corpus cavernosum of diabetic rats [29] and
supports functional findings in vascular tissues showing that
endothelium- dependent vasodilatations may be at least partially
reliant on nNOS-related mechanisms [30].
Enhanced reactive oxygen species (ROS) production is a main
factor in the pathogenesis of the vascular complications and
coronary artery disease in diabetes, and has been suggested to be
involved in the autonomic dysfunction of the rat diabetic heart and
penis [31,32]. Altered NOS function and NO bioavailability has
been mostly attributed to vascular superoxide production,
NADPH oxidase activation, dysfunctional eNOS and the
mitochondrial electron transport chain, being the main sources
of ROS generation [33].The findings in the present study suggest
Figure 5. NADPH oxidase inhibition restored the impaired neural relaxant responses in penile arteries form OZR. A, B. The
superoxide scavenger tempol (3610
25 M) had no effect on either the neural NO-mediated relaxations induced by EFS. C, D. Treatment with the
inhibitor of NADPH oxidase, apocynin (10
24 M) restored the EFS nitrergic relaxation in OZR arteries. E, F. Effects of tempol and apocynin on the
relaxant responses to the NO donor SNAP (10
28–3610
25 M) in penile arteries from LZR and OZR. Results are mean 6 SEM of 6–11 arteries. *P,0.05,
**P,0.01 vs control.
doi:10.1371/journal.pone.0036027.g005
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likely interfering with the NO signalling and thus impairing NO-
mediated neurogenic relaxant responses in arteries from OZR, as
depicted by augmented superoxide levels and the beneficial effect
of the NADPH oxidase inhibitor apocynin on the relaxations
induced by both exogenous and neural-derived NO in the erectile
tissue of obese animals.
Superoxide production by vascular tissues and its interaction
with NO might generate the powerful oxidative and highly toxic
peroxynitrite radical, that causes oxidative damage to DNA,
proteins and lipids, eNOS uncoupling, augmented apoptosis and
tissue injury and inflammation [33]. Nitrosative stress induced
either directly by metabolic disturbances within the neuron or
indirectly by vascular dysfunction has been implicated in the
diabetic neuropathy [15,21,34]. In the present study, nitrosative
stress was demonstrated in the penile erectile tissue from OZR by
the enhanced nitrotyrosine immunostaining mainly found in the
vascular endothelium of penile arteries, in the endothelium lining
the cavernous spaces and eventually in nerve trunks close to
arteries and sinuses in the penis of insulin resistant OZR.
Peroxynitrite can oxidize and reduce the availability of the NOS
cofactor BH4 and also reduce cellular transport of the eNOS
substrate L-arginine, causing eNOS uncoupling. Uncoupled
eNOS generates superoxide instead of NO that continues to alter
cell signalling processes in vascular endothelial and smooth muscle
cells [35,36,37]. eNOS uncoupling and endothelial dysfunction
have recently been demonstrated in models of hypercholesterol-
emia- and age-related ED [38,39]; however, there is limited
information of the uncoupled nNOS to cause neural and vascular
dysfunction. Our results suggest that dysfunctional nitrergic
vasodilator responses in the penile circulation may be due to
decreased formation of NO because of uncoupled nNOS. Thus,
incubation with the substrate of NO synthesis L-arginine or
addition of the NOS cofactor, BH4, restored the nitrergic
relaxations induced by stimulation of the nerves in penile arteries
from OZR to levels similar to those in healthy arteries. The fact
that BH4 addition restored the impaired NO-mediated neural
responses in obese animals suggests NOS uncoupling because of
relative BH4 deficiency. Moreover, the paradoxical effect of the
Figure 6. Nitrotyrosine immunostaining for peroxynitrite and
superoxide production were elevated in the erectile tissue
from OZR. A–D. Nitrotyrosine immunoreaction was intense in OZR
and was mainly distributed in the endothelial cell layer (arrows) lining
penile arteries (B) and cavernosal spaces (D), and eventually in the
arterial smooth muscle (arrow heads) and in nerve trunks (double
arrows) close to the arteries (B). Nitrotyrosine immunoreaction was
slight in penile arteries (A) and corpus cavernosum (C) from LZR. E.
Basal superoxide production in corpus cavernosum tissue from LZR and
OZR detected by lucigenin-enhanced chemiluminescence. Effect of
tempol (3610
25 M) on the basal superoxide generated expressed in
counts per minute (cpm) per mg of tissue. Data are shown as the means
6 SEM of 6–7 corpus cavernosum samples. *P,0.05, **P,0.01 vs
control.
{{P,0.01 vs LZR.
doi:10.1371/journal.pone.0036027.g006
Figure 7. BH4 restored impaired neural NO-mediated vasore-
laxation of penile arteries from OZR. Effects of the NOS cofactor
BH4 (10
24 M) (A, B) the inactive pterin NH4 (10
25 M) (C, D). and the
inhibitor of the enzyme of BH4 synthesis GTP-cyclohydrolase-I (GCH-I,
3610
24 M) (E, F) on the relaxations induced by EFS in penile arteries
from LZR and OZR. Results are mean 6 SEM of 6–7 arteries. *P,0.05,
**P,0.01 vs LZR.
doi:10.1371/journal.pone.0036027.g007
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along with lack of effect of endothelial removal in arteries from
obese animals, further suggests that the neural nNOS isoform is
likely to be uncoupled and produces superoxide anions instead of
NO, superoxide in turn acting as vasoconstrictor factor.
Since ROS not only directly oxidize the eNOS cofactor BH4 to
BH2, but also trigger proteasome-dependent degradation of the
rate-limiting enzyme in BH4 synthesis, GCH-I [40], we assessed
the effects of GCH-I blockade on the neural relaxations of penile
arteries. This treatment significantly inhibited the EFS-induced
vasodilation only in LZR but not OZR indicating an altered
GCH-I enzyme function as a cause of BH4 deficiency and nNOS
uncoupling in OZR. These findings are consistent with the
reduced GCH expression recently shown in cerebral arteries from
insulin resistant OZR along with the augmented ROS production
due to uncoupling of both eNOS and nNOS [41].
On the other hand, the enhancing effect of L-arginine on the
impaired vasodilator responses to nerve stimulation of penile
arteries from OZR is consistent with earlier studies showing that
dietary L-arginine supplementation, as well as acute infusion of L-
arginine resulted in an improved NO release and enhanced both
endothelium and neural–dependent relaxations in the penis of
diabetic and aged rats [42,43,44]. Plasma concentration and
vascular content of L-arginine are reduced in experimental
diabetic animals [45] as well as in diabetic patients [46]. In the
present study, the beneficial effect of acute L-arginine adminis-
tration on the NO-mediated neural relaxant responses initially
suggests a deficiency in L-arginine in penile arteries under
conditions of metabolic syndrome. Since peroxynitrite can reduce
L-arginine transport into the cells by a nitrosative action on the L-
arginine transporter CAT-1 [47], oxidative stress and the high
levels of peroxynitrite found in the erectile tissue from insulin
resistant OZR might explain the acute effect of L-arginine to
restore the NO-mediate neural responses.
Finally, the present results demonstrate impaired NO signalling
in smooth muscle despite the unchanged relaxations elicited by
exogenous NO in penile arteries from OZR. Thus, the NO
relaxant responses were accompanied by decreases in intracellular
Ca
2+ in healthy arteries, probably as a result of an activation of
Ca
2+ and/or voltage dependent K
+ channels and subsequent
hyperpolarization [48,49], whereas in arteries from insulin
resistant animals, NO-elicited relaxations were significantly less
dependent on changes in intracellular Ca
2+ suggesting a greater
contribution of Ca
2+-independent mechanisms. The vasodilator
action of NO is in part mediated by Ca
2+ independent
mechanisms through an inhibition of RhoA-induced Ca
2+
sensitization and actin cytoskeleton organization [50]. Therefore,
the major involvement of Ca
2+ desensitization mechanisms in the
NO vasodilator action in OZR might be ascribed either to
impaired arterial K
+ channel function by peroxynitrite [51,52]
and/or to enhanced RhoK activity, as demonstrated in the penis
of diabetic animals [53] and in the augmented Ca
2+ sensitization
associated to vasoconstriction in penile arteries from insulin
resistant OZR [54]. Thus, enhanced RhoK activity due to
Figure 8. NO calcium signalling is impaired in penile arteries from OZR. A, C. Simultaneous recordings of [Ca
2+]i (top) and tension (bottom)
showing the effects of the NO donor SNAP (10
28–10
25 M) on Phe-precontracted penile arteries from LZR (A) and OZR (C). B, D. Summarized data
showing the changes in [Ca
2+]i and force in response to SNAP, and the impaired decrease in the [Ca
2+]i in response to the highest concentration
(10 mM) of SNAP applied in OZR (D). Responses are percentage of the rise in F340/F380 and contraction elicited by Phe. Results are mean 6 SEM of 5–6
arteries. {P,0.05 vs LZR.
doi:10.1371/journal.pone.0036027.g008
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signalling of erectile tissue under conditions of insulin resistance.
Sustained hyperglycemia, the hallmark of both type 1 and type
2 diabetes, is thought to be the driving force leading to oxidative
stress and to the signalling changes which damage penile nerves
and endothelium and reduce both nNOS and eNOS activity and
NO production. In hyperglycaemic models of insulin resistance/
type 2 diabetes, impaired erectile function was accompanied by a
slight [18] or nule [20] impairment of the neural NO-mediated
relaxant responses, which has led to the suggestion that
functionally altered nNOS-mediated signalling does not have
much pathophysiologic relevance to the development of ED in
these hyperglycaemic models of type 2 diabetes. In contrast, the
OZR displays only slight hyperglycemia but an abnormal lipidic
profile along with impaired erectile function [17,23]. The present
results first demonstrate impaired NO-mediated neural relaxation
of erectile tissue due to oxidative stress and nNOS uncoupling,
which along with endothelial dysfunction [23,24], likely contrib-
utes to ED under conditions of metabolic syndrome. Epidemio-
logical studies have identified dyslipidemia as an independent,
potentially modifiable factor for diabetic neuropathy [11] and it is
also a known risk factor for vasculogenic ED [2]. The present
study confirms that a nitrergic dysfunction involving nNOS
uncoupling and due to oxidative stress contributes to the
pathogenesis of ED under conditions of metabolic syndrome and
abnormalities in the lipid metabolism [38].
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